Amarin Corporation plc (ADR) Share Price Xetra
Equities
EH3A
US0231112063
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
||
0.675 EUR | 0.00% |
Sales 2024 * | 20Cr 19Cr 1.68TCr | Sales 2025 * | 21Cr 20Cr 1.79TCr | Capitalization | 29Cr 27Cr 2.4TCr |
---|---|---|---|---|---|
Net income 2024 * | -7Cr -6.54Cr -583.48Cr | Net income 2025 * | -6.4Cr -5.98Cr -533.47Cr | EV / Sales 2024 * | 1.21 x |
Net cash position 2024 * | 4.39Cr 4.1Cr 366.07Cr | Net cash position 2025 * | 16Cr 15Cr 1.32TCr | EV / Sales 2025 * | 0.6 x |
P/E ratio 2024 * |
-3.98
x | P/E ratio 2025 * |
-4.21
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.48% |
Latest transcript on Amarin Corporation plc (ADR)
Managers | Title | Age | Since |
---|---|---|---|
Aaron Berg
CEO | Chief Executive Officer | 61 | 01/12/01 |
Thomas Reilly
DFI | Director of Finance/CFO | 52 | 20/22/20 |
Compliance Officer | 55 | 15/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Louis Sterling
BRD | Director/Board Member | 45 | 28/23/28 |
Odysseas Kostas
CHM | Chairman | 49 | 28/23/28 |
Keith Horn
BRD | Director/Board Member | 66 | 28/23/28 |
1st Jan change | Capi. | |
---|---|---|
+16.13% | 12TCr | |
+19.65% | 11TCr | |
+18.86% | 2.65TCr | |
-23.84% | 1.94TCr | |
-18.19% | 1.62TCr | |
-45.95% | 1.52TCr | |
-19.28% | 1.54TCr | |
+63.81% | 1.49TCr | |
+1.94% | 1.35TCr |
- Stock Market
- Equities
- AMRN Stock
- EH3A Stock